These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8865249)

  • 1. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.
    Hoppe B; Graf D; Offner G; Latta K; Byrd DJ; Michalk D; Brodehl J
    Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
    McConnell KN; Rolton HA; Modi KS; Macdougall AI
    Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
    Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxalate removal by differing dialysis techniques.
    Dell'Aquila R; Feriani M; Mascalzoni E; Bragantini L; Ronco C; La Greca G
    ASAIO J; 1992; 38(4):797-800. PubMed ID: 1450473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic renal replacement therapy in children: which index is best for adequacy?
    Verrina E; Brendolan A; Gusmano R; Ronco C
    Kidney Int; 1998 Nov; 54(5):1690-6. PubMed ID: 9844146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of children following the initiation of dialysis: a comparison of three dialysis modalities.
    Kaiser BA; Polinsky MS; Stover J; Morgenstern BZ; Baluarte HJ
    Pediatr Nephrol; 1994 Dec; 8(6):733-8. PubMed ID: 7696115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with hemodialysis and peritoneal dialysis.
    Suzuki H; Hoshi H; Inoue T; Kikuta T; Tsuda M; Takenaka T
    Contrib Nephrol; 2012; 177():71-83. PubMed ID: 22613917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
    Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
    Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis.
    Keshaviah PR; Nolph KD; Van Stone JC
    Perit Dial Int; 1989; 9(4):257-60. PubMed ID: 2488377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.
    Ebihara I; Nakamura T; Takahashi T; Tomino Y; Shimada N; Koide H
    Perit Dial Int; 1997; 17(6):595-601. PubMed ID: 9655160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
    Lightfoot BO; Caruana RJ
    Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term survival between hemodialysis and peritoneal dialysis.
    Maiorca R; Cancarini GC; Brunori G; Zubani R; Camerini C; Manili L; Movilli E
    Adv Perit Dial; 1996; 12():79-88. PubMed ID: 8865878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.